MBX Biosciences, Inc. Common Stock
MBX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$0 | -$0 | -$0 |
| % Margin | – | – | – |
| Net Income | -$0 | -$0 | -$0 |
| % Margin | – | – | – |
| EPS Diluted | -1.85 | -1.02 | -0.82 |
| % Growth | -81.4% | -24.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 |